TYRA
Tyra Biosciences·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 2
Bearish Engulfing
Ample Liquidity
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About TYRA
Tyra Biosciences, Inc.
A precision oncology company that developing purpose-built therapies to overcome tumor resistance
2656 State Street, Carlsbad, CA 92008
--
Tyra Biosciences, Inc., was incorporated in Delaware on August 2, 2018. The company is a precision oncology company focused on developing specialized therapies to overcome tumor resistance and improve treatment outcomes for cancer patients. The company is using its proprietary SNAP platform, which is optimized to rapidly and precisely improve structural design through iterative molecular SNAPshots to generate next-generation product candidates specifically designed to address acquired resistance and provide alternative treatment options.
Company Financials
EPS
TYRA has released its 2025 Q3 earnings. EPS was reported at -0.5, versus the expected -0.51, beating expectations. The chart below visualizes how TYRA has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
